Eckrich Jonas, Zissler Ulrich M, Serve Friederike, Leutz Patricia, Smaczny Christina, Schmitt-Grohé Sabina, Fussbroich Daniela, Schubert Ralf, Zielen Stefan, Eickmeier Olaf
Department of Pediatric Pulmonology, Allergy and Cystic Fibrosis, University Children's Hospital, Goethe-University, Frankfurt, Germany.
Department of Pediatric Pulmonology, Allergy and Cystic Fibrosis, University Children's Hospital, Goethe-University, Frankfurt, Germany; Center of Allergy & Environment (ZAUM), Technical University of Munich and Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany.
J Cyst Fibros. 2017 Jan;16(1):107-115. doi: 10.1016/j.jcf.2016.05.016. Epub 2016 Jun 11.
Airway infection and inflammation play major roles in the progression of cystic fibrosis (CF) lung disease. In patients with mild disease, airway inflammation is a clinically relevant and often underdiagnosed feature. Lung function, sputum cell counts, and cytokine profiles in CF with mild disease might be different in patients with and without involvement of small airway disease (SAD).
Patients with mild CF (n=32) and 22 healthy controls were enrolled in this study. Patients with CF were assigned to two groups: (1) patients without SAD (n=19, median age 12.3years, MEF>50% predicted), and (2) patients with SAD (n=13 median age, 13.2years, MEF<50% predicted). Lung function parameters were measured, cells in induced sputum were counted, and cytokines/chemokines (IL-1β, IL-6, IL-8, TNF-α) were analyzed by real-time quantitative PCR (qRT-PCR) and cytometric bead array (CBA).
Patients with CF had significant elevated levels of pro-inflammatory genes in qRT-PCR and secreted gene products in CBA compared to controls. Patients with CF and SAD had significantly increased trapped air (RV/TLC) and pronounced airway inflammation compared to controls as indicated by elevated levels of sputum biomarkers like total cells, neutrophils, and IL6.
Our study demonstrated that patients with CF with mild disease defined by lung function might be further endotyped according to their involvement of SAD. In patients with CF and SAD, airway neutrophilic inflammation is more pronounced and is in part distinct from that seen in patients without SAD.
气道感染和炎症在囊性纤维化(CF)肺病进展中起主要作用。在轻度疾病患者中,气道炎症是一个具有临床相关性且常被漏诊的特征。轻度CF患者的肺功能、痰液细胞计数和细胞因子谱在合并或未合并小气道疾病(SAD)的患者中可能有所不同。
本研究纳入了32例轻度CF患者和22例健康对照。CF患者被分为两组:(1)无SAD患者(n = 19,中位年龄12.3岁,最大呼气中期流速[MEF]>预测值的50%),以及(2)有SAD患者(n = 13,中位年龄13.2岁,MEF<预测值的50%)。测量肺功能参数,计数诱导痰液中的细胞,并通过实时定量聚合酶链反应(qRT-PCR)和细胞计数珠阵列(CBA)分析细胞因子/趋化因子(白细胞介素-1β[IL-1β]、IL-6、IL-8、肿瘤坏死因子-α[TNF-α])。
与对照组相比,CF患者在qRT-PCR中促炎基因水平显著升高,在CBA中分泌基因产物水平显著升高。与对照组相比,合并SAD的CF患者残气量/肺总量(RV/TLC)显著增加,气道炎症明显,痰液生物标志物如总细胞、中性粒细胞和IL-6水平升高表明了这一点。
我们的研究表明,根据肺功能定义的轻度CF患者可能根据其是否合并SAD进一步进行内型分类。在合并SAD的CF患者中,气道中性粒细胞炎症更明显,且部分不同于未合并SAD的患者。